• Neopterin is a by-product of guanosine triphosphate metabolism and is produced by macrophages in response to lymphocytic activation. We have studied serum neopterin levels in patients with Guillain-Barré syndrome to obtain further evidence of immune activation in this disease. Serum neopterin levels were significantly elevated in patients with Guillain-Barré syndrome compared with patients with other peripheral neuropathies and multiple sclerosis and with healthy control subjects. Serial analysis demonstrated that as neopterin levels fell, the clinical status of the patients with Guillain-Barré syndrome improved and soluble interleukin 2 receptor levels dropped. Thus, lymphocytic and macrophage activation may play a role in the pathogenesis of Guillain-Barré syndrome.
Bansil S, Mithen FA, Singhal BS, Cook SD, Rohowsky-Kochan C. Elevated Neopterin Levels in Guillain-Barré Syndrome: Further Evidence of Immune Activation. Arch Neurol. 1992;49(12):1277–1280. doi:10.1001/archneur.1992.00530360079021
Neurology in JAMA: Read the Latest
Customize your JAMA Network experience by selecting one or more topics from the list below.